Novartis hits acquisition trail

Swiss pharmaceuticals giant Novartis is set to become the world’s biggest maker of generic drugs after today announcing the details of an acquisition spree worth €5.65bn.

Basel-based Novartis has agreed to buy Germany’s Hexal and a majority stake in United States-based Eon Labs.